AssayIndex

GGPE-2510-R9180

Retatrutide · 10 mg declared · Nantong Guangyuan Chemical Co., Ltd. · manufactured 26 Oct 2025

CHARACTERISED
Lot code
GGPE-2510-R9180
Supplier
GGPeps — Nantong Guangyuan Chemical Co., Ltd.
Compound
Retatrutide
Compound class
Incretin analogues and co-agonists
Declared label claim
10mg
Manufacture date
26 Oct 2025
Index quarter
2026-Q1
Independent assays
14
Laboratories involved
Janoshik, Kestrel, PeptideMeter, Medutest, Nordanalyt
Provenance mix
Buyer-sourced ×1 · Supplier-supplied ×12 · Laboratory-retained ×1
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 14
Median purity 99.39% n=14
Spread (max − min) 1.30pp n=14
Standard deviation 0.428pp n=14
95.196.096.897.798.699.4100.3This lot (GGPE-2510-R9180)This lot (GGPE-2510-R9180): Q1 99.06, median 99.39, Q3 99.75, n=14n=14All RetatrutideAll Retatrutide: Q1 97.75, median 98.41, Q3 98.87, n=496outlier 95.45outlier 95.54outlier 95.67outlier 95.97n=496 Purity (% area)
Figure 1. This lot's independent purity results against the whole Retatrutide record set in the index. The vertical line is the index acceptance specification for the incretin analogues and co-agonists class, 96.5 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 14

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042671GGPE-2510-R9180Janoshik2026-Q199.763.3692.4Supplier-supplied1MARGINAL
AX-2026-042672GGPE-2510-R9180Kestrel2026-Q198.854.07Supplier-supplied2MARGINAL
AX-2026-042673GGPE-2510-R9180PeptideMeter2026-Q198.874.41Supplier-supplied2MARGINAL
AX-2026-042674GGPE-2510-R9180PeptideMeter2026-Q198.583.35Supplier-supplied2MARGINAL
AX-2026-042675GGPE-2510-R9180PeptideMeter2026-Q199.233.2697.2Supplier-supplied1MARGINAL
AX-2026-042676GGPE-2510-R9180Janoshik2026-Q199.193.36Supplier-supplied3MARGINAL
AX-2026-042677GGPE-2510-R9180Medutest2026-Q199.453.4592.1Laboratory-retained1MARGINAL
AX-2026-042678GGPE-2510-R9180Medutest2026-Q199.883.4189.0Supplier-supplied4MARGINAL
AX-2026-042679GGPE-2510-R9180Janoshik2026-Q199.333.10Buyer-sourced1MARGINAL
AX-2026-042680GGPE-2510-R9180Nordanalyt2026-Q199.802.96Supplier-supplied2MARGINAL
AX-2026-042681GGPE-2510-R9180Kestrel2026-Q199.852.79Supplier-supplied1MARGINAL
AX-2026-042682GGPE-2510-R9180Janoshik2026-Q199.023.3698.4Supplier-supplied3FAIL
AX-2026-042683GGPE-2510-R9180Janoshik2026-Q199.673.39Supplier-supplied1MARGINAL
AX-2026-042684GGPE-2510-R9180Janoshik2026-Q199.743.37Supplier-supplied2MARGINAL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik699.76, 99.19, 99.33, 99.02, 99.67, 99.7499.5030min+0.0099.50
Kestrel298.85, 99.8599.3515min+0.2499.11
PeptideMeter398.87, 98.58, 99.2398.8728min-0.0598.92
Medutest299.45, 99.8899.6625min+0.0899.58
Nordanalyt199.8099.8035min+0.0299.78

This lot contributes 10 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)99.5499.76divergence +0.15 pp vs batch median
Total impurities (% area)0.460.24
Largest single impurity (% area)not stated0.16
Water (%)2.33.36
Counter-ion (%)not stated6.18
Peptide content (%w/w)not stated90.09
Endotoxin (EU/mg)not statednot determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
C18 diacid regioisomer14 / 140.270.06–0.85
truncated (5-39)14 / 140.070.02–0.18
incomplete Fmoc removal (+222 Da)12 / 140.070.02–0.42
[D-Aib2]-diastereomer7 / 140.230.03–0.32
oxidised Trp (+16 Da)7 / 140.040.03–0.07
aspartimide (−18 Da)5 / 140.060.03–0.10
des-Aib20 analogue1 / 140.02
Section 7

What this rollup does not establish